Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Combined Malonic and Methylmalonic Aciduria (CMAMMA): Gene Identification and Outcome Study

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2010 by McGill University Health Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
McGill University Health Center
ClinicalTrials.gov Identifier:
NCT01289158
First received: February 2, 2011
Last updated: February 7, 2011
Last verified: October 2010

February 2, 2011
February 7, 2011
February 2011
February 2012   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01289158 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Combined Malonic and Methylmalonic Aciduria (CMAMMA): Gene Identification and Outcome Study
Not Provided

The investigators are interested in learning more about the changes found in the condition called "Combined elevation of Malonic and MethylMalonic Acid, or CMAMMA. " Malonic, or MA and MethylMalonic, or MMA, are acids formed from the breakdown of protein under normal conditions. However, in the condition called CMAMMA there is an increase of these acids in the blood and urine, which is not normal.

Some people with high MA and MMA in their blood and urine have a serious disease, starting as a baby or young child that includes heart disease and problems in learning. These people have changes in a special enzyme called Malonyl CoA Decarboxylase (MCD). Other people who have a high level of MA and MMA do not have any obvious illness. The investigators are not sure why they have high levels of MA and MMA and why they are not sick.

The goal of this study is to learn more about why some people have a high level of MA and MMA and to make sure there are no medical problems as a result of these high levels. The investigators also want to find out which gene and enzyme cause the high levels of MA and MMA.

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Retention:   Samples With DNA
Description:
  1. A 5 cc sample of blood from a vein in EDTA tube for DNA testing
  2. A 5 cc sample of urine sample to measure the levels of MA and MMA
  3. An additional 5 cc (1 tsp) of blood sample will be collected from the parents for DNA testing
Non-Probability Sample

Biochemical Genetics clinics patients with non-classical CMAMMA

  • Malonic Aciduria
  • Methylmalonic Acidemia
Not Provided
non-classical CMAMMA, classical CMAMMA
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
6
February 2012
February 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Elevated Malonic and Methylmalonic Acid in blood and urine
  2. Any age
  3. Any sex
  4. Asymptomatic

Exclusion Criteria:

  1. Defect in malonyl-coenzyme A decarboxylase (MCD) enzyme
  2. History of metabolic acidosis, developmental delay and seizures
Both
Not Provided
Yes
Contact: Ahmed Alfares, M.B.B.S 5144124427 ahmed.alfares@mail.mcgill.ca
Canada
 
NCT01289158
10-131-PED
No
Dr. Nancy Braverman, The Research Institute of the MUHC | McGill University Health Centre
McGill University Health Center
Not Provided
Not Provided
McGill University Health Center
October 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP